Alzheimer's

Our specialists are nationally recognized for their innovative management and treatment of this disease

Alzheimer’s disease is a common disease that affects memory and thinking ability. It is the most common cause of dementia and results in the progressive deterioration of brain cells.

At the IU Health Neuroscience Center, our specialists are nationally recognized for their management and treatment of the disease.

The disease starts gradually. People with early-onset Alzheimer's, in particular, are often misdiagnosed with stress or depression.

At IU Health your physicians will use advanced technology to help diagnose Alzheimer's disease. No matter what the age of onset, you need an accurate, early diagnosis so that you can begin medication to control symptoms.

No single test confirms the diagnosis of Alzheimer's disease. The disease is diagnosed with the following:

  • A physical and neurological exam
  • Laboratory testing
  • Cognitive testing.

To rule out other neurological conditions, your physicians at IU Health will use advanced brain-imaging technology, including:

Diagnosis

The disease starts gradually. People with early-onset Alzheimer's, in particular, are often misdiagnosed with stress or depression.

At IU Health your physicians will use advanced technology to help diagnose Alzheimer's disease. No matter what the age of onset, you need an accurate, early diagnosis so that you can begin medication to control symptoms.

No single test confirms the diagnosis of Alzheimer's disease. The disease is diagnosed with the following:

  • A physical and neurological exam
  • Laboratory testing
  • Cognitive testing.

To rule out other neurological conditions, your physicians at IU Health will use advanced brain-imaging technology, including:

A cure for Alzheimer's disease does not currently exist. Medication can help manage symptoms. Sometimes it delays progression in some people in the early stages of the disease.

The IU Center for Alzheimer's Disease and Related Disorders at Indiana University School of Medicine performs leading edge Alzheimer’s research.

Working with the IU School of Medicine, the Alzheimer’s team works to find better treatment options to discover better diagnostic and risk factors for earlier treatment.

With more than 13 active studies and clinical trials, researchers can accelerate the fight to end Alzheimer’s for the next generation.

Treatment

A cure for Alzheimer's disease does not currently exist. Medication can help manage symptoms. Sometimes it delays progression in some people in the early stages of the disease.

The IU Center for Alzheimer's Disease and Related Disorders at Indiana University School of Medicine performs leading edge Alzheimer’s research.

Working with the IU School of Medicine, the Alzheimer’s team works to find better treatment options to discover better diagnostic and risk factors for earlier treatment.

With more than 13 active studies and clinical trials, researchers can accelerate the fight to end Alzheimer’s for the next generation.

Early-onset Alzheimer’s Disease Study

Early-onset Alzheimer’s affects people under the age of 65. It can start in people in their 30s and 40s. The IU School of Medicine is studying advance early-onset Alzheimer’s to support future treatment options. The Longitudinal Early-onset Alzheimer’s Disease Study (LEADS) will address major gaps in disease research. The study will follow participants ages 40-64 years. LEADS is enrolling participants at research sites across the country. Learn more about this study, including enrollment criteria.

Research

Early-onset Alzheimer’s Disease Study

Early-onset Alzheimer’s affects people under the age of 65. It can start in people in their 30s and 40s. The IU School of Medicine is studying advance early-onset Alzheimer’s to support future treatment options. The Longitudinal Early-onset Alzheimer’s Disease Study (LEADS) will address major gaps in disease research. The study will follow participants ages 40-64 years. LEADS is enrolling participants at research sites across the country. Learn more about this study, including enrollment criteria.

Mar 07

The end of the beginning for Alzheimer's patients

Leo Stenz is the first IU Health patient to receive a new alzheimer's medication that's shown to significantly slow a patient's cognitive decline.

The end of the beginning for Alzheimer's patients image.

Patient Stories for Alzheimer's

Mar 07

The end of the beginning for Alzheimer's patients

Leo Stenz is the first IU Health patient to receive a new alzheimer's medication that's shown to significantly slow a patient's cognitive decline.

The end of the beginning for Alzheimer's patients image.

Medline Plus

MedlinePlus is the National Institutes of Health's Web site for patients and their families and friends. The website has information about diseases, conditions, and wellness issues.

Alzheimer’s Foundation of America

The Alzheimer’s Foundation of America’s (AFA) mission is to provide optimal care and services to individuals living with Alzheimer’s disease and related illnesses and to their families and caregivers.

Alzheimer's Association

This website offers information on Alzheimer's disease and dementia symptoms, diagnosis, stages, treatment, care and support resources.

Resources

Medline Plus

MedlinePlus is the National Institutes of Health's Web site for patients and their families and friends. The website has information about diseases, conditions, and wellness issues.

Alzheimer’s Foundation of America

The Alzheimer’s Foundation of America’s (AFA) mission is to provide optimal care and services to individuals living with Alzheimer’s disease and related illnesses and to their families and caregivers.

Alzheimer's Association

This website offers information on Alzheimer's disease and dementia symptoms, diagnosis, stages, treatment, care and support resources.